home / articles

Articles and News Articles from the OTCMKTS, NASDAQ and NYSE markets

Now Trending
Company Name:LogicMark Inc Com Par$ (New)
Stock Symbol:LGMK
Market:NASDAQ
Website:logicmark.com
Menu
LGMK LGMK Quote LGMK Short LGMK News LGMK Articles LGMK Message Board
Get Alerts

News, Short Squeeze, Breakout and More Instantly...

Search

ASND - $1000 Invested In Ascendis Pharma 10 Years Ago Would Be Worth This Much Today | Benzinga

Ascendis Pharma (NASDAQ:ASND) has outperformed the market over the past 10 years by 43.24% on an annualized basis producing an average annual retur...

BMRN - $100 Invested In Biomarin Pharmaceutical 20 Years Ago Would Be Worth This Much Today | Benzinga

Biomarin Pharmaceutical (NASDAQ:BMRN) has outperformed the market over the past 20 years by 6.44% on an annualized basis producing an average annua...

FITB - Why Fifth Third Might Surprise This Earnings Season | Benzinga

Investors are always looking for stocks that are poised to beat at earnings season and Fifth Third Bancorp (NASDAQ: FITB) may be one such company. ...

RAYS - What's Going On With Enphase Energy Stock Today? | Benzinga

Enphase Energy, Inc. (NASDAQ:ENPH) unveiled its latest Enphase Energy System, introducing the new IQ Battery 5P alongside IQ8 Microinverters, for c...

TAN - What's Going On With Enphase Energy Stock Today? | Benzinga

Enphase Energy, Inc. (NASDAQ:ENPH) unveiled its latest Enphase Energy System, introducing the new IQ Battery 5P alongside IQ8 Microinverters, for c...

ENPH - What's Going On With Enphase Energy Stock Today? | Benzinga

Enphase Energy, Inc. (NASDAQ:ENPH) unveiled its latest Enphase Energy System, introducing the new IQ Battery 5P alongside IQ8 Microinverters, for c...

SILO - Silo Pharma Finds Partner For Device Development for Intranasal PTSD Drug | Benzinga

Silo Pharma Inc (NASDAQ:SILO) stock is surging on Thursday, with a session volume of 88 million compared to an average volume of 3.2 million, as pe...

CTAS - Cintas Surpasses Q4 Earnings and Revenue Estimates | Benzinga

Cintas (NASDAQ: CTAS) came out with quarterly earnings of $3.99 per share, beating the Zacks Consensus Estimate of $3.80 per share. This compares t...

TEX - Cintas Surpasses Q4 Earnings and Revenue Estimates | Benzinga

Cintas (NASDAQ: CTAS) came out with quarterly earnings of $3.99 per share, beating the Zacks Consensus Estimate of $3.80 per share. This compares t...

BOKF - Synovus Q2 Earnings Beat Estimates, Revenues Fall Y/Y | Benzinga

Synovus Financial Corp. (NYSE: SNV) reported second-quarter 2024 adjusted earnings per share of $1.16, which surpassed the Zacks Consensus Estimate...

Previous 10 Next 10